devinitorg/iati-policy-markers huggingface dataset:
NIHR HPSR-DA: Accelerating the development of Health Policy and Systems Research capacity in Western Pacific Region for health system strengthening Health systems in many countries in the WHO Western Pacific Region (WPR) must respond to changing health needs driven by demographic and economic transition, demanding strengthening of universal health coverage and health system reforms. Yet there is limited health policy and systems research (HPSR) capacity to inform these changes. This project will build HPSR capacity, which is critical to strengthening health systems. A training programme based on global HPSR competencies will be implemented in Malaysia and extended to other WPR countries where there is buy-in, with the aim of creating an international community of practice and a body of policy-relevant research to support health reform. It will be delivered by a consortium comprising the Institute for Health Systems Research (IHSR), the United Nations University-International Institute for Global Health (UNU-IIGH), University of the Philippines Manila (UP Manila) and the London School of Hygiene & Tropical Medicine(LSHTM). 1) Design and field-test an HPSR training programme in Malaysia. An initial needs assessment will help tailor this to diverse audiences. Internationally agreed HPSR competencies will be adapted to the country context, creating a package that is supported by key actors and can be scaled up nationally. An innovative theory of change will be applied to track training outcomes and processes,documenting what works, where, and when.
2) Undertake HPSR capacity mapping in Malaysia and selected WPR countries where there is demand, to identify capacity gaps, national priorities and opportunities to align HPSR training with national health policies (e.g. the Philippines).
3) Learn from the Malaysian experience to develop locally-led, country-specific plans and strategies for scaling up HPSR capacity in these WPR countries.
4) Develop proposals for HPSR projects that address important health system or health service needs in Malaysia and elsewhere in WPR and seek national/regional endorsement and funding.
5) Document and disseminate Malaysian and WPR country experiences through Health Systems Global (HSG), providing a roadmap to accelerate the expansion of HPSR capacity in other low and middle-income countries.
NIHR Global Health Research Group on Stillbirth Prevention and Management in Sub-Saharan Africa A UK and low- and middle-income country (LMIC) partnership that aims to improve the prevention and management of stillbirth. This research has the direct and primary aim of improving the health, wellbeing and economic development of people in LMICs. 1) Prevention of stillbirth through improved identification of women with high risk pregnancies. We will explore how mother’s reporting of reduced baby movements during late pregnancy (a low cost method used widely in high income countries to alert clinicians to poor growth) could be adapted for use in LMIC settings. 2) Better childbirth care by examining factors which influence how women seek and access care, the quality of the care received and specific causes of stillbirth in local healthcare facilities, using new effective tools. 3) Ensuring humane and respectful care for bereaved parents through understanding the experiences of women, partners and health workers after stillbirth.
NIHR RIGHT2: Behavioural activation intervention for depression and diabetes in South Asia A UK and low- and middle-income country (LMIC) research partnership that aims to develop and evaluate a culturally adapted behavioural activation intervention for people with depression and diabetes in Bangladesh and Pakistan. The project aims to develop and test a culturally appropriate treatment for depression in people with diabetes in Bangladesh and Pakistan. This will be based on a relatively simple psychological talking treatment called Behavioural Activation (BA). The projects objectives are:
1. Develop and evaluate a culturally relevant, scalable behavioural activation intervention that can be delivered by non-specialists, and integrated within diabetes care. 
2. Evaluate the clinical cost effectiveness of the new intervention in comparison to optimised usual care practices.
3. Evaluate the economic impacts of diabetes and depression multimorbidities. 
The work will generate knowledge that can improve mental and physical health, reduce inequalities and stigma for vulnerable groups, and provide economic benefit. Research collaboration is also expected to lead to further enhanced capacity in applied mental-physical multimorbidity research and policymaking in Bangladesh and Pakistan.
NIHR Global Health Research Group on Building partnerships for resilience: strengthening grassroots response to public health crises The aim of The Partnerships for Resilience Group is to develop and strengthen the evidence base for how to improve effective community-led responses to environment-related public-health crises. To do this the Group will establish and capacity strengthen an international partnership to conduct excellent research to inform policy and practice.

Human health and wellbeing face severe, interconnected threats from increasingly frequent and disruptive shocks, including outbreaks (some pandemic) of zoonotic infections (e.g. Ebola, Covid19) as well as severe environmental change, heightened by climate change, that lead to changes in food security, disease patterns and disasters. Social science work has shown that resilience for responding to such shocks is most effectively built at community level. However, no good quality data exist on the mechanisms by which effective health responses to crises can be built. The Group will gather evidence with local partners in Ethiopia, Madagascar, Sierra Leone and Uganda, which have experienced – and responded to – a range of public health crises.

Central to our approach is the “co-production” of research actions with affected communities. We will gather evidence and conduct case study analyses to develop prototype approaches to developing community-led approaches to emergency-response. We will then test and evaluate these using participatory methods. We will refine and finalise our Prototypes in the light of our findings and then widely disseminate them to key decisions makers in governments and international agencies in order to improve the resilience and effectiveness of responses to public health crises. Our overarching strategic aim is to develop and strengthen a newly expanded international partnership to conduct research to inform policy and practice that improves effective community-led responses to public-health crises.

Our five objectives, are to:
1) Synthesise evidence on how communities, local health systems and other formal and informal entities have responded to health crises, and with what effect:
2) Develop effective approaches for public health crisis-response at grassroots:
3) Evaluate models for effective community-led responses to public-health crises. 
4) Formulate guidance and create dialogue with stakeholders on how to strengthen local resilience for effective responses to public health crises.
5) Strengthen and consolidate sustainable partner research and management capacities to strengthen policy and practice in crisis-response.
NIHR Global Health Research Group on Warfarin Anticoagulation in Patients with Cardiovascular Disease in Sub-Saharan Africa A UK and low- and middle-income country (LMIC) partnership that aims to improve anticoagulation with warfarin - an important area of unmet medical need in LMICs - by developing context-appropriate dosing algorithms, and further improve anticoagulation quality by using novel technological advances. This research has the direct and primary aim of improving the health, wellbeing and economic development of people in LMICs. 1. Evaluate the quality of anticoagulant services in Cape Town and rural and urban Uganda. 2. Recruit patients currently on warfarin to identify clinical and other non-genetic factors associated with poor anticoagulation control. 3. Develop a warfarin clinical dosing algorithm. 4. Evaluate genes specific to the local African populations in Uganda and South Africa that can impact on anticoagulation control, and the development of a novel genetic dosing algorithm. 5. Initiate a study to implement the clinical dosing algorithm in the two sites. Objectives for new work packages are: 
1. Develop protocols and guidance documents for the bundle, according to SQUIRE guidelines
(squirestatement.org) and attain necessary governance approvals; 2. Develop locally-appropriate training packages to ensure hospital staff are aware of the bundle aims to support adherence and educate patients; 3. Work with local patient groups to co-create tools to support adherence and educate patients; 4. Implement the bundle in hospitals (in Kampala & Cape Town) and their down-referral anticoagulation clinics; 5. Assess the clinical effectiveness and cost effectiveness of the bundle; 6. Assess staff and patient views on the bundle.
NIHR Global Health Research Unit on Health System Strengthening in Sub-Saharan Africa A UK and low- and middle-income country (LMIC) partnership that aims to work across primary care, maternal and surgical care platforms, to develop, adapt and evaluate health system strengthening interventions to enhance the processes and outcomes of evidence-based care. This research has the direct and primary aim of improving the health, wellbeing and economic development of people in LMICs. 1) Identify and evaluate system approaches to enhance guideline operationalisation; more explicit care pathways, manualised interventions, and technologies to improve detection/diagnosis (guideline optimisation). 2) Identify health system-strengthening needs for more effective delivery of GBC (health system assessment/diagnostic phase). 3) Develop and refine content and delivery of tailored health-system strengthening interventions (HSSI) with rigorous piloting and evaluation (development and piloting phase). 4) Evaluate the effects of scaling-up the resulting health system strengthening interventions (HSSI) package, on guideline-based care (GBC) processes and outcomes.
European and Developing Countries Clinical Trials Partnership (EDCTP) phase II: funding for programme management activities The UK Department of Health and Social Care (DHSC) funds outstanding global health research through the National Institute for Health and Care Research (NIHR). The European & Developing Countries Clinical Trials Partnership (EDCTP) funds clinical research to accelerate the development of new or improved drugs, vaccines, microbicides and diagnostics against HIV/AIDS, tuberculosis and malaria as well as other poverty-related infectious diseases in sub-Saharan Africa, with a focus on phase II and III clinical trials. The NIHR provided a funding contribution to EDCTP 2 programme management activities. This activity is a component of European and Developing Countries Clinical Trials Partnership (EDCTP) phase II programme (GB-GOV-10-EDCTP2). Support the European & Developing Countries Clinical Trials Partnership to effectively deliver EDCTP2 programmes.
Applied Research for Adolescent Health in Low and Middle Income Countries The UK Department of Health and Social Care (DHSC) funds outstanding global health research through the National Institute for Health and Care Research (NIHR). This programme is administered by the UK Medical Research Council (MRC), which reports activities under the UK Department for Business, Energy and Industrial Strategy (BEIS). NIHR disburses funds to MRC, which makes onwards disbursements to awardees. This initiative funds research grants to improve adolescent health in low- and middle-income countries (LMICs). The aim of this programme is to generate new knowledge to contribute to improving the effectiveness and accessibility of health interventions that will results in improved adolescent health in low- and middle-income countries.
National Institute for Health and Care Research (NIHR)’s fourth Global Research Professorship call National Institute for Health and Care Research (NIHR)’s fourth Global Research Professorship call. The Global Research Professorships programme funds research leaders, with a track-record of applied health research in low- and middle-income countries (LMICs), to promote effective translation of research and to strengthen research leadership at the highest academic levels. Funding of up to £2m over up to 5 years is awarded to Professors working in close partnership with a research institution in an LMIC. By the end of the award, NIHR Global Research Professors will be expected to: 

1) Have demonstrated research leadership at a national and/or international level.
2) Have been developed and protected by their institutions, including being relieved of administrative tasks.
3) Enhance existing and establish new research collaborations in low- and middle-income countries (LMICs).
4) Have supported training and capacity strengthening/mentorship within LMIC and UK (if applicable) institutions that enhances research capacity for future global health and care research.
Health Policy and Systems Research to tackle low vaccine acceptance in low- and middle-income countries (LMICs) A collaboration between the World Health Organization (WHO) Alliance for Health Policy and Systems Research (AHPSR) and the National Institute for Health and Care Research (NIHR) to support a call for Health Policy and Systems research proposals tackling the issue of low vaccine acceptance in low- and middle-income countries (LMIC). Improve the understanding of factors underlying low vaccine acceptance through formative and contextual analysis of supply- and demand-side constraints, including around the social determinants of health;   
Support the development of cutting-edge Health Policy and Systems Research (HPSR) that uses a variety of methods and approaches, including but not limited to participatory action research and ethnography to identify potential strategies to address low vaccine acceptance as well as appropriate methodologies (including the use of mixed methods approaches) to examine the implementation of these strategies in particular national/sub-national contexts; and  
Engage with governments at national and sub-national levels and with civil society to examine how learning can inform the development of programmes and policies to address challenges around vaccine acceptance.
NIHR HPSR-DA: Supporting those most in need: A partnership approach to strengthen health policy and systems research capacity in China and beyond This project seeks to build a platform to enable and support higher education and research institutions within and beyond China to systematically advance health policy and systems research (HPSR) to generate evidence for health systems strengthening in the most disadvantaged settings in the region and beyond, with lessons learned from the partnership benefitting low resource countries elsewhere. 1) Establish a partnership between Sun Yat-sen University Global Health Institute (SGHI), China, and the London School of Hygiene & Tropical Medicine(LSHTM), UK
2) Develop a consortium of SGHI-LSHTM and research collaborators from disadvantaged provinces in China (Gansu, Inner Mongolia) and Nepal
3) Conduct a review of health system challenges for most disadvantaged populations across China (Tibetan, Muslim and Mongol) and Nepal
4) Work with local stakeholders and communities using structured workshops to identify policy and HPSR priorities at regional level
5) Prepare a grant proposal addressing identified priorities using rigorous, multidisciplinary HPSR methods and approaches.
NIHR Research and Innovation for Global Health Transformation: Call 4 National Institute for Health and Care Research (NIHR)'s fourth Research and Innovation for Global Health Transformation (RIGHT) call. RIGHT funds cutting-edge interdisciplinary applied health research in key areas in low- and middle-income countries (LMICs) where a strategic and targeted investment can result in a transformative impact. 
RIGHT Call 4 supports equitable partnerships between LMIC and UK researchers to generate new research knowledge and evidence to address the global burden of unintentional injuries (including but not limited to road traffic accidents, falls, burns and drowning, and urgent and emergency care).
UK and LMIC-based universities and research institutes were invited to submit applications. Research must be focused on improving the health and welfare of people in LMICs. The aims of NIHR RIGHT Call 4 are to:
1. Deliver applied health research for the direct and primary benefit to the health and wealth of people living in ODA-eligible countries, with a focus on addressing the global burden of unintentional injuries and urgent and emergency care 
2. Ensure that the research funded through this call strengthens capacity for research and knowledge exchange through development of equitable partnerships between researchers in the ODA-eligible countries and the UK
3. Promote interdisciplinary approaches to working, by specifically encouraging applications necessitating expertise and activities associated with a broad range of health-science disciplines, including but not limited to: clinical, health economics, statistics, qualitative and social sciences.
Proposal and Partnership Development Awards (PPDA) for NIHR Research and Innovation for Global Health Transformation (RIGHT) call 2 Stage 2 applicants The purpose of Proposal and Partnership Development Awards (PPDA) funding is to improve the quality and likelihood of success of the projects funded through the NIHR Research and Innovation for Global Health Transformation (RIGHT) programme. Applicants that are successful at RIGHT Stage 1 and invited to submit a Stage 2 application are eligible for a PPDA, subject to satisfactory submission of a PPDA application. Not all Stage 2 applicants awarded a PPDA go on to secure RIGHT programme funding. For RIGHT Call 2, PPDA were extended to 13 applicant organisations to support partnership development and the preparation of a RIGHT Stage 2 application. Proposal and Partnership Development Awards (PPDA) provide funding of up to £10,000 for organisations applying to NIHR Research and Innovation for Global Health Transformation (RIGHT) programme funding to:
1.	Support applicants to work collaboratively with all study partners to develop the stage 2 application
2.	Enhance partnerships across the proposed research collaboration
3.	Initiate preparation of study governance documentation (i.e. due diligence and finance assurance policies)
PPDA funds must be spent between the notification of RIGHT stage 1 outcome and the submission of the RIGHT stage 2 application.
Proposal and Partnership Development Awards (PPDA) for NIHR Research and Innovation for Global Health Transformation (RIGHT) call 3 Stage 2 applicants The purpose of Proposal and Partnership Development Awards (PPDA) funding is to improve the quality and likelihood of success of the projects funded through the NIHR Research and Innovation for Global Health Transformation (RIGHT) programme. Applicants that are successful at RIGHT Stage 1 and invited to submit a Stage 2 application are eligible for a PPDA, subject to satisfactory submission of a PPDA application. Not all Stage 2 applicants awarded a PPDA go on to secure RIGHT programme funding. For RIGHT Call 3, PPDA were extended to 12 applicant organisations to support partnership development and the preparation of a RIGHT Stage 2 application. Proposal and Partnership Development Awards (PPDA) provide funding of up to £10,000 for organisations applying to NIHR Research and Innovation for Global Health Transformation (RIGHT) programme funding to:
1.	Support applicants to work collaboratively with all study partners to develop the stage 2 application
2.	Enhance partnerships across the proposed research collaboration
3.	Initiate preparation of study governance documentation (i.e. due diligence and finance assurance policies)
PPDA funds must be spent between the notification of RIGHT stage 1 outcome and the submission of the RIGHT stage 2 application.
NIHR HPSR-DA: Integrating HIV Pre-exposure Prophylaxis and diagnostic STI care: an individualised public health approach (iPreP-STI) South Africa has some of the highest sexually transmitted infection (STI) and HIV rates globally. Syndromic treatment of STIs has poor sensitivity and specificity and could fuel antimicrobial resistance. STIs increase HIV transmission and acquisition; STIs and HIV disproportionately affect the most vulnerable groups in society resulting in poor health and economic burden. Taking advantage of the current roll-out of HIV Pre-Exposure Prophylaxis (PrEP) for adolescent girls and young women in South Africa, we aim to evaluate integrated models of diagnostic STI care using an individualised public health approach. We will 1) establish equitable research partnerships with a view to strengthening health system and research capacity for diagnostic STI care 2) engage policy makers, healthcare providers and patients in discrete choice experiments to establish preferences for diagnosis and treatment of STIs and assess the feasibility of integrating these within the South African health-system. 1) Set up equitable interdisciplinary partnerships to strengthen the health system, and build research capacity, in diagnostic STI care 
2) Use novel research methods to engage policy makers, facility managers, providers and service users in choice experiments in order to understand gaps in STI care and elicit their preferences for diagnoses and treatment 
3) Use interviews and focus group discussions to assess how feasible, acceptable and practical it would be to integrate a range of diagnostic and treatment approaches within the provision of PrEP.